BML, INC. (4694)

Market cap
¥163.7B
P/E ratio
25.2x
BML provides clinical laboratory testing services to hospitals and clinics across Japan, along with food safety testing and clinical trial support through its network of specialized subsidiaries.
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 2025-5,426-5.35%
Mar 31, 2024-5,733-40.99%
Mar 31, 2023-9,715-1.15%
Mar 31, 2022-9,828+190.60%
Mar 31, 2021-3,382-61.50%
Mar 31, 2020-8,784+188.85%
Mar 31, 2019-3,041+1.94%
Mar 31, 2018-2,983+4.45%
Mar 31, 2017-2,856-2.06%
Mar 31, 2016-2,916+3.92%
Mar 31, 2015-2,806
AI Chat